Early filing gives GSK a boost in COPD
Compelling data from FULFIL study puts GSK in pole position
X
Early filing gives GSK a boost in COPD
https://pharmaphorum.com/news/early-filing-gives-gsk-boost-copd/
Compelling data from FULFIL study puts GSK in pole position
